NCT05485831 Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY Status RECRUITING Phase N/A
NCT05472389 Neurodevelopmental Impact of Epilepsy on Autonomic Function in Dravet Syndrome Status ACTIVE_NOT_RECRUITING Phase NA
NCT05419492 A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome Status RECRUITING Phase PHASE1/PHASE2
NCT05364021 Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies Status COMPLETED Phase PHASE1/PHASE2
NCT05126914 Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents Status RECRUITING Phase N/A
NCT05044819 Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04740476 An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04614506 Transcranial Magnetic Stimulation to Measure Cortical Excitability in Dravet Syndrome Status UNKNOWN Phase N/A
NCT04611438 Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome Status UNKNOWN Phase PHASE3
NCT04537832 Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies Status TERMINATED Phase N/A
NCT04462770 A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome Status RECRUITING Phase PHASE3
NCT04442295 An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT04437004 Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol) Status APPROVED_FOR_MARKETING Phase N/A
NCT04069689 Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT03936777 A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome Status COMPLETED Phase PHASE3
NCT03650452 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies Status COMPLETED Phase PHASE2